NatWest Group Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing, dated November 18, 2025, serves as an initial notification of transactions by Persons Discharging Managerial Responsibilities (PDMRs) in accordance with Article 19 of the Market Abuse Regulation. The filing covers specific share purchases and option grants executed on November 14 and November 17, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This document is a regulatory disclosure of insider transactions rather than a financial results report.
Material Changes and Transactions
- Share Purchase: Joshua Critchley (Independent non-executive director) purchased 16,000 ordinary shares on November 17, 2025, at a price of £5.9840 per share on the London Stock Exchange.
- Option Grants: On November 14, 2025, options were granted under the 2017 UK ShareSave Plan with an exercise price of £4.6688 per share:
- Solange Chamberlain (CEO, Retail Banking): 781 options, exercisable from December 18, 2028 (3-year contract).
- James Holian (Chief Customer & Operations Officer): 781 options, exercisable from December 18, 2028 (3-year contract).
- Maria Kokkinou (Chief People Officer): 1,317 options, exercisable from December 18, 2030 (5-year contract).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of specific PDMR transactions.
Key Facts for Investor Verification
- Verify the current market price of NatWest Group shares relative to the PDMR purchase price of £5.9840.
- Confirm the terms of the 2017 UK ShareSave Plan regarding the exercise price of £4.6688 and vesting schedules.
- Review the total shareholding positions of the named PDMRs following these transactions.